177614-63-0

Upstream product

• 3744-87-4 Boc-(R)-Ala 
• 100-39-0 benzyl bromide 
• 4248-19-5 tert-butyl carbazate 
• 55895-92-6 benzyl 2-diazopropanoate 

Downstream Products

• 17831-02-6 D-alanine benzyl ester 
• 936703-31-0 C₁₉H₂₈N₂O₆ 
• 47711-92-2 H-L-Lys(Z)-D-Ala-OBzl 
• 55533-19-2 Boc-L-Tyr(Bzl)-D-Ala-OBzl 
• 18814-51-2 Boc-L-Lys(Z)-D-Ala-OBzl 
• 153461-23-5 H-L-Pro-D-Ala-OBzl 
• 374116-14-0 benzyl (tert-butoxycarbonyl)-L-leucyl-D-alaninate 
• 374116-17-3 Boc-L-Pro-D-Ala-OBzl 
• 374116-15-1 Boc-L-Ser(Bzl)-D-Ala-OBzl 
• 374116-18-4 Boc-L-Trp-D-Ala-OBzl 
• 374116-16-2 Boc-L-Glu(O-cHex)-D-Ala-OBzl 
• 374116-20-8 Boc-L-His(Bom)-D-Ala-OBzl 
• 374116-50-4 Boc-L-Pro-D-Ala-L-Leu-D-Ala-OBzl 

Relevant academic research and scientific papers

NOVEL COMPOUNDS

A compound of formula (I) or a pharmaceutically acceptable derivative thereof, (formula 1) wherein R1,R2, R3, R4, R5, X, m and n are defined in the specification; a process for preparing such compounds; a pharmaceutical composition comprising such compounds; and the use of such compounds in medicine.

Asymmetric Ni-H insertion reaction cooperatively catalyzed by rhodium and chiral spiro phosphoric acids

So near so SPA: Achiral dirhodium(II) carboxylates and chiral spiro phosphoric acids (SPA) cooperatively catalyzed asymmetric Ni-H insertion reactions with high enantioselectivity, high yields, and fast reaction rates at low catalyst loading (see scheme;

Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)

The present invention relates to compounds that inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes, especially type II diabetes, as well as hyperglycemia, Syndrome X, hyperinsulinemia, obesity, atherosclero

Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)

The present invention relates to compounds which inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes, especially type II diabetes, as well as hyperglycemia, Syndrome X, hyperinsulinemia, obesity, atheroscler

PHARMACEUTICAL COMPOSITIONS AS INHIBITORS OF DIPEPTIDYL PEPTIDASE-IV (DPP-IV)

The present invention relates to compounds which inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes, especially type II diabetes, as well as hyperglycemia, Syndrome X, hyperinsulinemia, obesity, atherosclerosis, and various immunomodulatory diseases.